...
首页> 外文期刊>Journal of hepato-biliary-pancreatic sciences >Metallic stents are more efficacious than plastic stents in unresectable malignant hilar biliary strictures: a randomized controlled trial.
【24h】

Metallic stents are more efficacious than plastic stents in unresectable malignant hilar biliary strictures: a randomized controlled trial.

机译:在无法切除的恶性肝门胆管狭窄中,金属支架比塑料支架更有效:一项随机对照试验。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Endoscopic biliary stenting is a well-established palliative treatment for unresectable malignant biliary strictures, for which plastic tube stents (PSs) and self-expandable metallic stents (SEMSs) are most commonly used. The efficacy of these stents has been extensively described in distal biliary strictures, but not in hilar biliary strictures. The present study aimed to compare the efficacy of PSs and SEMSs for unresectable malignant hilar biliary strictures.From June 2004 to November 2008, 60 patients were enrolled and prospectively randomized into the PS or SEMS group.The 6-month patency rate was significantly higher in the SEMS group than in the PS group (81 vs. 20%; p = 0.0012). Kaplan-Meier analysis showed significantly longer patency in the SEMS group than in the PS group (p = 0.0002); the 50% patency period was 359 days in the SEMS group and 112 days in the PS group. There was no significant difference in the overall survival period between the PS and SEMS groups (p = 0.2834). The mean number of reinterventions for stent failures was significantly lower in the SEMS group (0.63 times/patient) than in the PS group (1.80 times/patient) (p = 0.0008). The overall total cost for the treatment was significantly lower in the SEMS group than in the PS group (p = 0.0222).SEMSs were associated with a longer patency than PSs in patients with unresectable hilar biliary stricture. SEMSs were also more advantageous in reducing the number of reintervention sessions and the overall treatment cost.
机译:内镜胆道支架置入术是一种行之有效的姑息治疗,用于不可切除的恶性胆道狭窄,最常使用塑料管支架(PSs)和自扩张金属支架(SEMSs)。这些支架的功效已在远端胆道狭窄中广泛描述,但未在肝门胆道狭窄中描述。本研究旨在比较PSs和SEMSs对不可切除的恶性肝门胆管狭窄的疗效.2004年6月至2008年11月,有60例患者入选并前瞻性随机分为PS或SEMS组,其中6个月的通畅率明显高于对照组。 SEMS组比PS组(81%vs. 20%; p = 0.0012)。 Kaplan-Meier分析显示,与PS组相比,SEMS组的通畅时间明显更长(p = 0.0002)。 SEMS组的50%通畅期为359天,PS组为112天。 PS组和SEMS组之间的总生存期无显着差异(p = 0.2834)。在SEMS组中,支架失败的平均再干预次数(0.63次/患者)显着低于PS组(1.80次/患者)(p = 0.0008)。 SEMS组的总治疗费用明显低于PS组(p = 0.0222)。对于无法切除的肝门胆管狭窄患者,SEMSs的通畅时间长于PSs。 SEMS在减少再干预次数和总体治疗费用方面也更具优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号